Beyond the classic theranostic paradigm, the involvement of αvβ8 in major oncogenic pathways, such as TGF-β1 signaling and EMT, might ultimately render αvβ8-PET useful for clinical reasoning and personalized medicine, such as for cancer prognosis and stratification of patients for certain chemotherapies. The gene discussed is TGFB1; the disease is cancer.